Skip to main content

1 Result(s)

within Yoshikazu Johmura Remove this filter Medicine & Public Health Remove this filter

and

  1. Article

    Open Access

    Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance

    Sacituzumab govitecan is an antibody–drug conjugate that delivers SN-38, an active metabolite of irinotecan, to the target molecule, trophoblast cell-surface antigen 2 (Trop-2). It is a promising drug for trip...

    **g Zhu, Wenwen Wu, Yukiko Togashi, Naoe Taira Nihira, Yoshikazu Johmura… in Breast Cancer (2022)

    Download PDF (2309 KB) View Article